Synektik Spólka Akcyjna

Warsaw Stock Exchange SNT.WA

Synektik Spólka Akcyjna Operating Cash Flow for the year ending September 30, 2024: USD 22.87 M

Synektik Spólka Akcyjna Operating Cash Flow is USD 22.87 M for the year ending September 30, 2024, a 7.68% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Synektik Spólka Akcyjna Operating Cash Flow for the year ending September 30, 2023 was USD 21.24 M, a 1,805.02% change year over year.
Synektik Spólka Akcyjna Operating Cash Flow for the year ending September 30, 2022 was USD -1.25 M, a -122.88% change year over year.
Synektik Spólka Akcyjna Operating Cash Flow for the year ending September 30, 2021 was USD 5.45 M, a 51.29% change year over year.
Synektik Spólka Akcyjna Operating Cash Flow for the year ending September 30, 2020 was USD 3.60 M, a 6.74% change year over year.

Key data

Date	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid

Warsaw Stock Exchange: SNT.WA

Synektik Spólka Akcyjna

CEO	Mr. Cezary Dariusz Kozanecki
IPO Date	Aug. 1, 2011
Location	Poland
Headquarters	ul. Józefa Piusa Dziekonskiego 3
Employees	165
Sector	Healthcare
Industries Medical Instruments Biotechnology Defense & Military

Description

Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine; the development of IT solutions used in radiology; and produces and sells radiopharmaceutical products used in diagnostics for oncology. It also operates a research laboratory for diagnostic imaging systems and a service center for medical equipment. In addition, the company offers maintenance services for medical equipment, as well as acceptance and specialist tests. Synektik Spólka Akcyjna was founded in 2001 and is based in Warsaw, Poland.

Key trends

Past 5 years